 |
|
| Blog results | Results 1 - 10 of about 245,830 for plavix. (0.36 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Plavix Facing New Rival Blood Thinner - http://www.injuryboard.com/national-news/plavix-facing-new-rival-blood-thinner.aspx?googleid=270010 Joris Hoogendoorn - Fotografie - ... - http://www.jorishoogendoorn.com/ | |
| 19 Nov 2009 The pharmaceutical landscape is rapidly changing as patents for some of the blockbuster drugs of the last decade near expiration and other players try to grab some of the remaining revenues before ge. Minyanville - http://www.minyanville.com/ [ More results from Minyanville ] |
| 19 Nov 2009 Plavix (clopidogrel) has a very strong share of that, of course, but since Effient (prasugrel) was finally approved, Lilly and Dai-Ichii are looking to take as much of that market as they can. And one opening might be that not everyone ... In the Pipeline - http://pipeline.corante.com/ - References |
| 18 Nov 2009 by c.morrison@elsevier.com (Chris Morrison) The Food & Drug Administration's public health alert on Plavix is, as we point out in "The Pink Sheet" DAILY, a nice boost for Eli Lilly and Daiichi Sankyo, who market the competing platelet agent Effient. ... The IN VIVO Blog - http://invivoblog.blogspot.com/ - References [ More results from The IN VIVO Blog ] |
| 17 Nov 2009 BOSTON (MarketWatch) -- The Food and Drug Administration warned Tuesday that taking the blood-thinner Plavix with the antacid Prilosec can reduce Plavix's effectiveness by as much as half. Plavix, the world's second best-selling drug, ... MarketWatch.com - MarketPulse - http://www.marketwatch.com/Search/?doctype=-1&scid=0&mp=1&siteid=rss |
| 18 Nov 2009 The US Food and Drug Administration this week issued a new warning to healthcare providers and patients against the concomitant use of the anti-platelet agent Plavix (clopidogrel) and CYP2C19-inhibiting agents, but the agency ... Überfeed of All GenomeWeb Content - http://feeds.genomeweb.com/genomeweb [ More results from Überfeed of All GenomeWeb Content ] |
| 17 Nov 2009 by Pharma Marketer New data from a late-stage, head-to-head trial demonstrates that a group of the sickest heart attack patients taking AstraZeneca's experimental blood clot drug Brilinta experienced fewer serious... Read more... Pharma Marketer - http://pharma-marketer.brollyclient.ca/ [ More results from Pharma Marketer ] |
| 18 Nov 2009 by Tangaroa Snell The speculations regarding potent stomach-acid-reducing drug Prilosec reducing the benefit of plavix but data from more recent studies indicated that Prilosec and a similar drug Nexium might help patients on Plavix. ... TopNews New Zealand - http://topnews.net.nz/ - References |
| 20 Nov 2009 by alona Drug Store genaric buy Cheapest Plavix SALE Plavix Perth usa based pharmacy The Best Price, wher can i buy Plavix SALE Plavix Sydney cod HIGH QUALITY Pills buy cheap BEST PRICE Plavix SALE Plavix Melbourne next day delivery ... Invention Forum - Your Invention Community... - http://www.inventionforum.com/ [ More results from Invention Forum - Your Invention Community... ] |
| 19 Nov 2009 by The Happy Hospitalist Back in January 2009 I blogged about the possible deadily Plavix Prilosec interaction. Prilosec is an over the counter proton pump inhibitor (PPI). It inhibits the production of stomach acid, which helps reduce heart burn symptoms. ... The Happy Hospitalist - http://thehappyhospitalist.blogspot.com/ [ More results from The Happy Hospitalist ] |
| 18 Nov 2009 by Anna Tomova According to FDA, such a combination of drugs would only make anti-clotting Plavix dangerously ineffective. The second most prescribed drug in the world, Plavix blocks an enzyme in the body responsible for turning it into its active ... Visit Bulgaria - http://visitbulgaria.info/ [ More results from Visit Bulgaria ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
